Complete Filing Data
ZyVersa Therapeutics, Inc. reported Stockholders Equity of -$12.39 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean ZyVersa Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income * | -$25.0M | -$9.4M | -$98.3M | -$75.0K |
| Operating Income Loss | -$25.5M | -$9.1M | -$107.8M | -$820.1K |
| Research And Development Expense | $1.1M | $1.8M | $3.2M | $399.9K |
| Operating Expenses | $25.5M | $9.1M | $107.8M | $820.1K |
| General And Administrative Expense | $5.7M | $7.4M | $11.2M | $420.2K |
| Income Tax Expense Benefit | -$851.7K | $6.7K | -$9.5M | -$745.1K |
| Net Income Loss Available To Common Stockholders Basic | -$9.4M | -$106.2M | -$75.0K | |
| Interest Income Expense Net | -$513.2K | -$269.9K | $457.00 | -$427.5K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$25.8M | -$9.4M | -$107.8M | -$820.1K |
| Deferred Income Tax Liabilities Net | $851.7K | $844.9K | $10.3M | |
| Deferred Income Taxes And Tax Credits | -$851.7K | $6.7K | -$9.5M | -$745.1K |
| Goodwill Impairment Loss | $11.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$19.8M | -$2.2M | -$2.3M | -$2.4M | -$2.8M | -$2.8M | -$2.9M | -$78.5M | -$3.5M | -$679.1K | -$393.6K | -$720.0K | -$174.00 | -$789.00 | -$1.1K |
| Operating Income Loss | -$20.8M | -$2.0M | -$2.1M | -$2.3M | -$2.8M | -$2.8M | -$2.9M | -$86.3M | -$4.6M | -$985.6K | -$498.8K | -$801.0K | -$174.00 | -$789.00 | -$1.1K |
| Research And Development Expense | $365.1K | $409.9K | $258.9K | $436.0K | $709.0K | $512.9K | $673.9K | $1.2M | $1.1M | ||||||
| Operating Expenses | $20.8M | $2.0M | $2.1M | $2.3M | $2.8M | $2.8M | $2.9M | $86.3M | $4.6M | ||||||
| General And Administrative Expense | $1.7M | $1.6M | $1.9M | $1.8M | $2.0M | $2.3M | $2.2M | $3.9M | $3.5M | ||||||
| Income Tax Expense Benefit | -$851.7K | $9.7K | -$485.00 | -$7.8M | -$1.0M | $47.6K | |||||||||
| Net Income Loss Available To Common Stockholders Basic | -$2.4M | -$2.8M | -$2.9M | -$86.4M | |||||||||||
| Interest Income Expense Net | -$131.4K | -$130.0K | -$119.6K | -$131.6K | -$58.00 | -$101.00 | -$210.00 | -$314.00 | $1.1K | ||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$20.7M | -$2.2M | -$2.4M | -$2.8M | -$2.8M | -$2.9M | -$86.3M | -$4.6M | |||||||
| Deferred Income Tax Liabilities Net | $851.7K | $851.7K | $854.6K | $854.6K | $844.9K | $1.4M | $1.4M | $9.3M | |||||||
| Deferred Income Taxes And Tax Credits | -$1.0M | ||||||||||||||
| Goodwill Impairment Loss | $11.9M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity * | -$12.4M | $8.5M | $11.1M | $99.7M | -$2.3M | |
| Retained Earnings Accumulated Deficit | -$137.6M | -$112.6M | -$103.2M | -$4.9M | ||
| Liabilities Current | $12.7M | $11.2M | $10.2M | $8.2M | ||
| Liabilities And Stockholders Equity | $347.9K | $20.6M | $22.1M | $118.5M | ||
| Liabilities | $12.7M | $12.1M | $11.0M | $18.5M | ||
| Assets Current | $347.9K | $1.7M | $3.4M | $6.4M | ||
| Assets | $347.9K | $20.6M | $22.1M | $118.5M | ||
| Accrued Liabilities Current | $2.6M | $1.9M | $1.8M | $2.1M | ||
| Common Stock Value | $809.00 | $251.00 | $40.00 | $26.00 | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $101.8K | $1.5M | $3.1M | $5.9M | $328.6K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.4M | -$1.6M | -$2.8M | -$3.4M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $9.3M | |||||
| Cash | ||||||
| Accounts Payable Current | $10.1M | $9.3M | $8.4M | $6.0M | ||
| Derivative Liabilities Current | $560.6K | $788.7K | ||||
| Property Plant And Equipment Net | $6.9K | $17.3K | ||||
| Temporary Equity Carrying Amount Attributable To Parent | $331.3K | |||||
| Treasury Stock Common Shares | 7.00 | 7.00 | 7.00 | 0.00 | ||
| Other Assets Noncurrent | $18.6M | $18.6M | $100.1M | |||
| Operating Lease Right Of Use Asset | $7.8K | $98.4K | ||||
| Operating Lease Liability Current | $8.7K | $108.8K | ||||
| Prepaid Expense And Other Assets Current | $231.6K | $184.9K | $215.5K | $225.3K | ||
| Accounts Payable For Deferred Offering Costs | $17.1K | $44.9K | -$240.7K | |||
| Debt Instrument Unamortized Discount Current | $0.00 | $39.9K | ||||
| Treasury Stock Value | $7.2K | $7.2K | $7.2K | |||
| Goodwill | $11.9M | $11.9M | ||||
| Reclassification Of Formerly Redeemable Common Stock | $331.3K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | ||||||
| Preferred Stock Redeemed Or Called During Period Value | -$10.3M | |||||
| Preferred Stock Dividends Income Statement Impact | $7.9M | $10.0M | ||||
| Registered Offering Of Common Stock Value | $15.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$11.7M | $6.1M | $8.1M | $7.0M | $8.6M | $11.2M | $19.7M | $20.1M | $97.1M | -$4.2M | -$3.4M | -$3.0M | -$2.3M | -$1.4K | -$1.2K | -$439.00 | |
| Retained Earnings Accumulated Deficit | -$136.9M | -$117.1M | -$114.9M | -$111.2M | -$108.8M | -$106.0M | -$89.9M | -$87.0M | -$8.5M | -$4.2M | -$3.4M | -$3.0M | -$2.3M | ||||
| Liabilities Current | $12.8M | $12.7M | $12.0M | $11.5M | $10.0M | $9.6M | $11.7M | $10.5M | $8.6M | $1.6M | $775.5K | $828.5K | $276.8K | ||||
| Liabilities And Stockholders Equity | $1.0M | $19.6M | $21.0M | $19.4M | $19.5M | $21.7M | $32.9M | $32.0M | $115.0M | $79.4M | $79.2M | $79.7M | $77.1M | ||||
| Liabilities | $12.8M | $13.5M | $12.9M | $12.4M | $10.8M | $10.4M | $13.1M | $11.9M | $17.9M | $5.0M | $4.2M | $4.2M | $3.7M | ||||
| Assets Current | $995.5K | $549.1K | $2.1M | $390.4K | $641.4K | $2.9M | $2.0M | $1.1M | $2.8M | $438.6K | $566.6K | $1.1M | $1.2M | ||||
| Assets | $1.0M | $19.6M | $21.0M | $19.4M | $19.5M | $21.7M | $32.9M | $32.0M | $115.0M | $79.4M | $79.2M | $79.7M | $77.1M | ||||
| Accrued Liabilities Current | $3.0M | $2.9M | $2.4M | $2.3M | $1.7M | $1.5M | $2.8M | $2.3M | $2.1M | $1.6M | $775.5K | $828.5K | $200.2K | ||||
| Common Stock Value | $809.00 | $487.00 | $257.00 | $107.00 | $83.00 | $83.00 | $4.4K | $2.4K | $922.00 | $32.00 | $32.00 | $32.00 | $32.00 | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $528.0K | $72.1K | $1.6M | $122.9K | $119.5K | $2.0M | $1.6M | $228.7K | $1.3M | $830.2K | $667.00 | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $80.6K | -$1.1M | -$4.6M | ||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $1.6M | $228.7K | $1.3M | $5.9M | $213.6K | $340.0K | $928.4K | $686.5K | $702.5K | ||||||||
| Cash | $213.6K | $340.0K | $830.2K | $928.4K | |||||||||||||
| Accounts Payable Current | $9.8M | $9.8M | $9.6M | $9.3M | $8.3M | $8.1M | $8.9M | $8.1M | $6.4M | ||||||||
| Derivative Liabilities Current | |||||||||||||||||
| Property Plant And Equipment Net | $1.7K | $4.3K | $9.5K | $12.1K | $14.7K | ||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $78.6M | $78.4M | $78.4M | $75.8M | |||||||||||||
| Treasury Stock Common Shares | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 2.2K | 2.2K | |||||||||
| Other Assets Noncurrent | $18.6M | $18.6M | $18.6M | $18.6M | $30.8M | $100.1M | |||||||||||
| Operating Lease Right Of Use Asset | $31.1K | $53.9K | $76.3K | ||||||||||||||
| Operating Lease Liability Current | $34.3K | $59.6K | $84.5K | ||||||||||||||
| Prepaid Expense And Other Assets Current | $298.2K | $378.7K | $498.8K | $267.5K | $521.9K | $866.5K | $426.5K | ||||||||||
| Accounts Payable For Deferred Offering Costs | |||||||||||||||||
| Debt Instrument Unamortized Discount Current | |||||||||||||||||
| Treasury Stock Value | $7.2K | $7.2K | $7.2K | $7.2K | $7.2K | $7.2K | $7.2K | $7.2K | |||||||||
| Goodwill | $11.9M | ||||||||||||||||
| Reclassification Of Formerly Redeemable Common Stock | -$331.3K | ||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$98.2K | $702.5K | $667.00 | ||||||||||||||
| Preferred Stock Redeemed Or Called During Period Value | -$215.0K | -$10.1M | |||||||||||||||
| Preferred Stock Dividends Income Statement Impact | $32.4K | $7.9M | |||||||||||||||
| Registered Offering Of Common Stock Value | $1.6M | $9.8M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$5.1M | -$7.5M | -$8.7M | -$3.4M |
| Net Cash Provided By Used In Financing Activities | $3.7M | $5.9M | $6.0M | $1.9M |
| Increase Decrease In Accounts Payable | $689.3K | $888.6K | $2.4M | -$2.1M |
| Share Based Compensation | $222.8K | $705.6K | $1.2M | $56.3K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $46.8K | -$30.6K | -$56.5K | -$36.6K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $717.3K | $139.5K | $101.5K | -$715.7K |
| Increase Decrease In Operating Lease Liability | -$8.7K | -$100.1K | -$4.8K | |
| Increase Decrease In Vendor Deposits | $80.0K | -$136.5K | -$125.6K | |
| Proceeds From Issuance Initial Public Offering | $18.1M | |||
| Increase Decrease In Security Deposits | $161.9K | -$80.0K | ||
| Proceeds From Issuance Of Private Placement | $2.0M | $2.0M | ||
| Proceeds From Warrant Exercises | $10.0M | $2.7M | $1.1K | |
| Net Cash Provided By Used In Investing Activities |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q1 2025 | Q3 2024 | Q1 2024 | Q1 2023 | Q1 2022 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$1.8M | -$3.8M | -$4.6M | -$98.2K | -$48.1K | |||
| Net Cash Provided By Used In Financing Activities | $1.9M | $2.7M | -$34.7K | $2.7M | $750.6K | $667.00 | ||
| Increase Decrease In Accounts Payable | $191.4K | -$303.8K | $355.4K | $1.7K | $1.1K | |||
| Share Based Compensation | $72.3K | $223.6K | $287.5K | |||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $313.9K | $651.0K | $1.1M | |||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $445.1K | -$299.6K | $59.3K | |||||
| Increase Decrease In Operating Lease Liability | -$8.7K | -$24.2K | ||||||
| Increase Decrease In Vendor Deposits | ||||||||
| Proceeds From Issuance Initial Public Offering | ||||||||
| Increase Decrease In Security Deposits | ||||||||
| Proceeds From Issuance Of Private Placement | $2.1M | $2.0M | $828.0K | |||||
| Proceeds From Warrant Exercises | $2.7M | |||||||
| Net Cash Provided By Used In Investing Activities | -$2.7M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Earnings Per Share Basic | $-4.18 | $-8.48 | $-1,089.70 | $-0.29 | |
| Weighted Average Number Of Shares Outstanding Basic | 6.0M | 1.1M | 97.5K | 257.6K | |
| Earnings Per Share Diluted | $-4.18 | $-8.48 | $-1,089.70 | $-0.29 | |
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M | 250.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Diluted Shares Outstanding | 6.0M | 1.1M | 97.5K | 257.6K | |
| Common Stock Shares Issued | 8.1M | 2.5M | 405.2K | 257.6K | |
| Common Stock Shares Outstanding | 8.1M | 2.5M | 402.2K | 257.6K | |
| Temporary Equity Shares Outstanding | 0.00 | 1.9K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Earnings Per Share Basic | $-2.56 | $-0.46 | $-0.73 | $-2.43 | $-3.31 | $-4.53 | $-30.18 | $-1,694.12 | $-135.88 | |||
| Weighted Average Number Of Shares Outstanding Basic | 7.7M | 4.8M | 3.1M | 988.4K | 834.9K | 623.6K | 97.3K | 51.0K | 26.1K | |||
| Earnings Per Share Diluted | $-2.56 | $-0.46 | $-0.73 | $-2.43 | $-3.31 | $-4.53 | $-30.18 | $-1,694.12 | $-135.88 | |||
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 110.0M | 110.0M | 110.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Diluted Shares Outstanding | 7.7M | 4.8M | 3.1M | 988.4K | 834.9K | 623.6K | 97.3K | 51.0K | 26.1K | |||
| Common Stock Shares Issued | 8.1M | 4.9M | 2.6M | 1.1M | 834.9K | 834.9K | 43.5M | 23.7M | 9.2M | |||
| Common Stock Shares Outstanding | 8.1M | 4.9M | 2.6M | 1.1M | 834.9K | 834.9K | 43.5M | 23.7M | 9.2M | |||
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $222.8K | $705.6K | $1.2M | $56.3K | |
| Depreciation | $6.9K | $10.4K | $532.00 | ||
| Additional Paid In Capital | $125.2M | $121.2M | $114.3M | $104.6M | |
| Derivative Gain Loss On Derivative Net | -$607.0K | $228.1K | |||
| Other Noncash Expense | $7.8K | $90.5K | $4.4K | ||
| Prepaid Expense Current | |||||
| Stock Issued During Period Value Issued For Services | $240.0K | $196.8K | $671.6K | ||
| Security Deposit | $98.5K | $46.7K | |||
| Operating Costs And Expenses | |||||
| Vendor Deposit | |||||
| Issuance Of Stock And Warrants For Services Or Claims | $240.0K | $196.8K | $671.6K | ||
| Stock Redeemed Or Called During Period Value | $331.3K | ||||
| Stock Issued During Period Value Other | -$5.5K | ||||
| Stock Issued During Period Value New Issues |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $74.0K | $59.2K | $72.3K | $160.7K | $160.7K | $223.6K | $243.0K | $365.7K | $287.5K | ||||||||
| Depreciation | $2.6K | $2.6K | |||||||||||||||
| Additional Paid In Capital | $125.2M | $123.2M | $123.0M | $118.2M | $117.4M | $117.3M | $109.6M | $107.0M | $105.6M | $22.00 | $22.00 | $22.00 | |||||
| Derivative Gain Loss On Derivative Net | |||||||||||||||||
| Other Noncash Expense | $7.8K | $22.0K | |||||||||||||||
| Prepaid Expense Current | $886.9K | $1.3M | $225.3K | $225.0K | $226.5K | $225.0K | $251.8K | ||||||||||
| Stock Issued During Period Value Issued For Services | $29.6K | $128.8K | $81.6K | $79.2K | $210.0K | $395.2K | |||||||||||
| Security Deposit | $46.7K | ||||||||||||||||
| Operating Costs And Expenses | $985.6K | $498.8K | $801.0K | $174.00 | $789.00 | $1.1K | |||||||||||
| Vendor Deposit | $235.0K | $235.0K | |||||||||||||||
| Issuance Of Stock And Warrants For Services Or Claims | $81.6K | $79.2K | $395.2K | ||||||||||||||
| Stock Redeemed Or Called During Period Value | $331.3K | ||||||||||||||||
| Stock Issued During Period Value Other | -$34.7K | ||||||||||||||||
| Stock Issued During Period Value New Issues | $395.2K | $667.00 |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.